To offer IGeL individually... and to concentrate on the appropriate patients
Thomas, A.
MMW Fortschritte der Medizin 148(47): 58-59
2006
ISSN/ISBN: 1438-3276 PMID: 17168193 Document Number: 598141
Document emailed within 1 workday
Related Documents
Flach, M.; Böhme, W. 1981: Individually manufactured plastic canulas for laryngectomized patients Laryngologie Rhinologie Otologie 60(7): 359-360Wallace, J.D. 1975: Serving our patients individually remains basic concept of medicine Canadian Medical Association Journal 113(8): 770
Kainz, H.; Weissel, M. 1990: Can the thyrotropin (TSH) suppressive dose of L-thyroxine (T4) be individually predicted in athyroid patients? Acta Medica Austriaca 17(2-3): 50-54
Walbert, H. 2013: Which M-IIi or M-IV service can i claim with IGeL? MMW Fortschritte der Medizin 155(10): 10
Misselwitz, F.; Norden, C.; Heine, H. 1988: Individually controlled acetylsalicyclic acid (ASA) in the long-term treatment of patients with arteriosclerosis Biomedica Biochimica Acta 47(10-11): S303-S306
Malm, U. 1990: Rehabilitation of schizophrenic patients demands an individually based combination of psychosocial therapy and medicine Lakartidningen 87(43): 3492
Hakimi, R. 2006: Hormone substitution--a questionable IGeL indication MMWFortschrittederMedizin 148(27-28): 16
Hering, T. 2002: Smoking cessation as IGeL procedure. Cost effective for physician and patient MMW Fortschritte der Medizin 144(18): 52
Henn, A.; Hoffmann, R.; Müller, H.A. 1988: Haptoglobin determination in the serum of patients following intraoperative autotransfusion using the Haemonetics Cell Saver III. Studies on the loading of patients with free hemoglobin in retransfused erythrocyte concentrate Der Anaesthesist 37(12): 741-745
B1uchard, S.; Gauthier, J.; Laberge, B.; Plamondon, J. 1995: What psychotherapy to offer to anxious patients? L'Union Medicale du Canada 124(3): 14-19
Frye, J.P. 1984: Hospitals offer incentives to attract patients Medical World News 25(19): 70-71
Baratto, F.; Michielan, F.; Gagliardi, G.; Di Gregorio, G.; Pasqualetto, A.; Meroni, M.; Giron, G.P. 2004: Use of protein C concentrate in adult patients with severe sepsis and septic shock Minerva Anestesiologica 70(5): 351-356
Eguchi, Y.; Yoshida, T.; Okabe, H. 2011: How to use AT concentrate or recombinant thrombomodulin for the patients with sepsis analyzed by laboratory markers Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 147: 213-215
Bezares, R.; Murro, H.; Díaz, A.; Cavagnaro, F.; Caviglia, D.; Santomé, J. 1997: Prevention of infections in patients with lymphoproliferative syndromes and myeloma by nebulization of an IgA concentrate Sangre 42(3): 219-222
Kunst, V.A.; Nováková, I.R.; Haanen, C. 1989: Cryoprecipitate should have preference over factor VIII concentrate in the treatment of patients with hemophilia A Nederlands Tijdschrift Voor Geneeskunde 133(23): 1163-1166
Zhuk, E.A.; Zelenkov, V.N. 1997: Topinambur concentrate in the treatment of patients with insulin-dependent diabetes mellitus Voprosy Pitaniia 56(6): 34-36
Marchack, C.B. 2003: What can we offer patients with today's advancements in dental materials? Journal of the California Dental Association 31(4): 339-340
Belinfante, L.S. 1990: Contemporary oral and maxillofacial surgery: what does it offer our patients? Dentistry Today 9(5): 30-31
Pettenazzo, A.; Malusa, T. 2004: Use of protein C concentrate in critical conditions: clinical experience in pediatric patients with sepsis Minerva Anestesiologica 70(5): 357-363
Ewing, N.P. 1990: Induction of immune tolerance with factor VIIi concentrate in patients with hemophilia a and inhibitors Progress in Clinical and Biological Research 324: 59-68